CCL11 and glioblastoma: We further analyzed the correlation between CCL11/CCR3 expression with other clinic-pathologic characteristics, and developed a prognostic classifier combining expression of CCL11 and CCR3 with Karnofsky performance status (KPS) for predicting one-year survival in GBM patients.